1.22% 0.13

Bioventus Inc (BVS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Bioventus Inc-Aktie (BVS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-27	2025-06-28	2025-03-29	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.88% 157.90	138.65	147.66	123.88	153.64
Cost Of Revenue	10.57% 49.12	44.42	45.57	40.82	50.99
Gross Profit	15.44% 108.78	94.23	102.09	83.06	102.66
Operating Expenses	7.62% 89.30	82.98	83.72	78.19	94.67
Benefits Costs and Expenses	7.30% 143.76	133.98	137.35	127.29	153.41
Costs And Expenses	7.30% 143.76	133.98	137.35	127.29	153.41
Depreciation and Amortization	7.22% 1.297	1.398	1.439	1.593	1.768
Operating Income/Loss	73.18% 19.49	11.25	18.37	4.869	7.988
Nonoperating Income/Loss	18.82% -5.343	-6.582	-8.055	-8.286	-7.756
Income/Loss From Continuing Operations Before Tax	202.85% 14.14	4.67	10.31	-3.417	0.232
Income Tax Expense/Benefit	578.16% -3.175	0.664	1.041	-0.095	0.55
Income/Loss From Continuing Operations After Tax	332.30% 17.32	4.006	9.272	-3.322	-0.318
Net Income/Loss	332.30% 17.32	4.006	9.272	-3.322	-0.318
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	201.18% 2.563	0.851	1.813	-0.685	-0.162
Basic Average Shares	99.79% 0.1395	66.92	66.50	66.01	0.3126
Diluted Average Shares	99.82% 0.1228	68.84	68.54	66.01	0.3126
Basic Earnings Per Share	340.00% 0.22	0.05	0.11	-0.04	-
Diluted Earnings Per Share	320.00% 0.21	0.05	0.11	-0.04	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.60

1.02%

STE

$215.44

1.43%

DXCM

$64.99

0.75%

PHG

$27.97

1.10%

GEHC

$70.74

0.64%

$81.99

3.20%